Now showing 1 - 9 of 9
No Thumbnail Available
Publication

Spielentscheidend : Der Staat als M&A-Akteur

2011-02-01 , Kunisch, Sven , Wahler, Caspar , Müller-Stewens, Günter

No Thumbnail Available
Publication

M&A-Rechtsentwicklungen - Blicke zurück und nach vorn

2010 , Binder, Andreas , Müller-Stewens, Günter , Kunisch, Sven , Binder, Andreas

No Thumbnail Available
Publication

Gerds, Johannes: Post Merger Integration. Eine empirische Untersuchung zur Integrationsforschung, Gabler Verlag und Deutscher Universitäts-Verlag, Wiesbaden 2000

2003 , Müller-Stewens, Günter

No Thumbnail Available
Publication

Mergers & Acquisitions : Analysen, Trends und Best Practices

2010 , Müller-Stewens, Günter , Kunisch, Sven , Binder, Andreas

No Thumbnail Available
Publication

Konsequenzen aus der Finanzmarktkrise für den Markt der Unternehmenskontrolle

2009 , Müller-Stewens, Günter

No Thumbnail Available
Publication

Eine Schwalbe macht noch keinen Sommer

2014-09-20 , Müller-Stewens, Günter , Düsterhoff, Henning

No Thumbnail Available
Publication

Wachstum durch Mergers und Acquisitions

2012 , Müller-Stewens, Günter , Spanninger, Johanna , Zentes, Joachim , Swoboda, Bernhard , Morschett, Dirk , Schramm-Klein, Hanna

No Thumbnail Available
Publication

The Acquisition of Aventis by Sanofi. Attack as Defense, Play 2: The closing and integration of Sanofi-Aventis

2008 , Müller-Stewens, Günter , Alscher, Alexander , Zentes, Joachim , Swoboda, Bernhard , Morschett, Dirk

The year 2004 started with a bombshell for the M&A sector: On 24th January rumors emerged of an imminent takeover bid by Sanofi-Synthélabo to the shareholders in Aventis. On 25th April 2004, the first hostile takeover in the history of the pharmaceuticals sector was completed. The CEO of Sanofi and future CEO of Sanofi-Aventis, Jean-Francois Dehecq, commented: "I had a very strong feeling that if we didn't do this deal now then one of our international competitors would have bought either Aventis or Sanofi." The aim of this case study is to describe an entire M&A process - against the background of a pharmaceuticals industry undergoing highly dynamic competition and consolidation. The case is outlined in a chronological form, from the first rumors through to the fierce takeover battle, the amicable unification , and finally the integration of Sanofi-Aventis.

No Thumbnail Available
Publication

Ein starker Franken macht noch keine Akquisition

2011-08-27 , Müller-Stewens, Günter